GRG's Center For Experiential Learning

Emerging therapies like complement and FcRn inhibitors are reshaping Myasthenia Gravis care, offering more targeted and effective options for patients. But with challenges in diagnosis, access, and long-term safety still in play, the road ahead demands innovation, collaboration, and a patient-centered approach.

In an era where technological advancements and patient-centric care dominate the healthcare industry, innovation is no longer a luxury...

The global microneedle market is undergoing significant growth, driven by advances in healthcare technology, rising consumer demand for...

Healthcare is experiencing a revolution. Advances in technology are reshaping how care is delivered, especially through remote patient...

In recent years, Remote Patient Monitoring (RPM) has emerged as one of the most promising advancements in healthcare technology. As a...

The healthcare industry has undergone significant transformations in recent years, with technology playing a crucial role in reshaping...